The cell culture market has emerged as an important subject area in the fields of biotechnology and pharmaceutical industry. Cell culture involves growing eukaryotic or prokaryotic cells in an artificial controlled environment with a special growth medium. These cells can be derived from plants or animals and are allowed to grow, interact, and divide. Cell culture provides an ideal platform for understanding various aspects of cell physiology outside the body and helps in drug development processes.
The Global cell culture market is estimated to be valued at US$ 19,198.0 Mn in 2024 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to 2030.
Key Takeaways
Key players operating in the cell culture market are Corning Incorporated, Merck KGaA, Sartorius AG, BioSpherix, Ltd., Cell Culture Company, LLC, Thermo Fisher Scientific Inc., VWR International LLC, and Lonza. These players are focusing on new product launches and expansions to strengthen their market position. For instance, in 2021, Merck launched new cell culture media to support cell therapy research and developments.
The demand for cell culture products is driven by the increasing investments in pharmaceutical and biotech research and rising prevalence of chronic diseases worldwide. Biopharmaceutical companies are engaged in developing novel biologic drugs for the treatment of diseases like cancer, cardiovascular, and infectious diseases which requires extensive cell-based research.
Technological advancements like automated cell culture systems, serum-free media, and animal component-free solutions are helping researchers to gain insights faster. Developments in 3D cell culture techniques that can better mimic in vivo environments are further expected to provide a boost to the market.
Market Trends
Single-use bioreactors : Single-use bioreactors that minimize the risks of contamination and reduce production timelines are being increasingly adopted by biopharma players for monoclonal antibody production and viral vaccine manufacturing.
Stem cell banking: Established companies are entering stem cell banking to facilitate clinical research in regenerative medicine. Increasing stem cell therapy treatments will drive the demand for reliable stem cell banking solutions.
Market Opportunities
Personalized medicine: Advancements in genomic sequencing technologies are enabling the development of novel personalized therapy approaches. This will open opportunities for developing patient-specific induced pluripotent stem (iPS) cell lines.
Developing markets: Emerging economies in Asia Pacific and Latin America are witnessing significant growth in biotech industry. Leading players can expand their presence in these regions to tap into the opportunity.
Impact of COVID-19 on the Cell Culture Market
The outbreak of COVID-19 has significantly impacted the growth of the cell culture market globally. During the initial months of the pandemic in 2020, lockdowns and restrictions enforced by various governments disrupted the supply chain and halted research activities involving cell culture techniques. This led to a decline in the demand for cell culture products such as media, reagents, and instruments. However, with increasing research focused on developing vaccines and therapeutics for COVID-19, the demand started picking up from late 2020. Researchers extensively used cell culture to study virus-host interactions and screen potential drug candidates. This boosted the usage of cell culture consumables like serum and growth factors. Going forward, as research continues on SARS-CoV-2 virus and its emerging variants, cell culture is expected to play a vital role, sustaining the market growth. Though the pandemic slowed down other non-COVID research temporarily, government funding is now promoting multi-disciplinary studies involving cell culture. This is likely to further support the market in the post-pandemic years.
Geographical Regions with Significant Cell Culture Market Value
North America accounts for the major share of the global cell culture market in terms of value, owing to the large biopharmaceutical industry and advanced research infrastructure in the US and Canada. The rising prevalence of chronic diseases and increasing R&D spending on developing novel therapeutics have been propelling the demand for cell-based research techniques in the region. Asia Pacific is poised to be the fastest growing regional market, driven by rising healthcare expenditure, improving research capabilities, and favorable policies supporting pharmaceutical businesses in China, India, and other developing nations. Rapid expansion of the biotech sector and growing contract research outsourcing are attracting global players to invest in the cell culture infrastructure in Asia Pacific countries.
Geographical Region Witnessing Fastest Growth in Cell Culture Market
Asia Pacific is projected to be the fastest growing regional market for cell culture during the forecast period from 2023 to 2030. This high growth is attributed to increasing government investments in life sciences research, rising biopharmaceutical production, and developing healthcare infrastructure in emerging economies of Asia Pacific. Countries like China and India offer low-cost and high-quality manufacturing capabilities attracting big pharmaceutical companies to establish production plants and R&D centers in the region. Growing contract research activities and the biologics boom are propelling cell culture adoption. Furthermore, government initiatives to promote local life sciences industries are augmenting regional capacities and competencies. All these factors together are fueling the cell culture market growth at a rapid pace in Asia Pacific.
Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.
(LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/
